Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

2007452 citationsReview

Authors

Asma Sultana · Cancer Research UK

Catrin Tudur Smith · Cancer Research UK

David Cunningham · University of Liverpool

Naureen Starling · University of Liverpool

John P. Neoptolemos · Cancer Research UK

Paula Ghaneh · Cancer Research UK

Abstract

There was a significant survival benefit for chemotherapy over best supportive care and gemcitabine combinations over gemcitabine alone. This supports the use of gemcitabine-based combination chemotherapy in the treatment of advanced pancreatic cancer.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Neuroblastoma Research and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 25, Issue 18, pp. 2607-2615

DOI: 10.1200/jco.2006.09.2551

Field-Weighted Citation Impact: 15.16